Raul Moreno

Raul Moreno

Interventional cardiologist / Cardiologist
Hospital Universitario La Paz - Madrid, Spain

Latest contributions

The rise of intracoronary imaging: current use and new tools

20 May 2025 – From EuroPCR 2025

Discover advances in intracoronary imaging including frequency of use, stent optimization benefits, and new technologies such as high-frequency saline OCT and deep learning plaque assessment. This session highlights clinical applications and innovative tools enhancing imaging quality and diagnostic accuracy.

The rise of intracoronary imaging: current use and new tools

Supraflex for high-risk patients and lesions: from practice to evidence-based medicine proven through FIRE and COMPARE

20 May 2025 – From EuroPCR 2025

Discover the latest evidence on the Supraflex thin-strut sirolimus DES in complex cases—from small vessels and diabetes to STEMI—supported by OCT analysis. This session highlights Supraflex’s performance in high bleeding risk and elderly patients, featuring data from FIRE, COMPARE, EARTH HBR, and Cruz Senior studies. Get...

Supraflex for high-risk patients and lesions: from practice to evidence-based medicine proven through FIRE and COMPARE

Managing TAVI complications

20 May 2025 – From EuroPCR 2025

Gain expertise in managing TAVI complications including strategic retrieval of embolized valves, handling unexpected additional valve usage, managing left ventricle suicide phenomenon, and integrating coronary intervention tools during structural heart procedures, supported by instructive case series.

Managing TAVI complications

TAV-in-TAV in complex situations

16 May 2024 – From EuroPCR 2024

This session comprises selected EuroPCR 2024 Clinical Case submissions focused on TAVI-in-TAVI procedures in complex situations. It covers various case presentations and discussions, including re-do TAVI with the risk of acute coronary obstruction, expanding possibilities in TAVR-in-TAVR with the mid-leaflet implantation technique, transcatheter valve-in-valve in self-expanding...

TAV-in-TAV in complex situations

TAVI: when calcifications are the major issues

16 May 2024 – From EuroPCR 2024

This session explores various challenging TAVI cases where severe aortic valve calcification was the main obstacle. Presenters share their experiences and strategies in overcoming these complex anatomical issues, including the use of techniques like the buddy balloon technique, snare technique, and innovative approaches to cross the...

TAVI: when calcifications are the major issues

TAVI essentials: anatomical factors, prosthesis selection, and complication management

02 Feb 2024 – From PCR Imaging Valves Madrid 2024

Discover a comprehensive exploration of critical considerations in TAVI in this section. From anatomical factors guiding the choice between TAVI and SAVR to strategies for selecting the optimal TAVI prosthesis for individual patients, each topic offers essential insights. Gain valuable insights into navigating TAVI for bicuspid...

TAVI essentials: anatomical factors, prosthesis selection, and complication management

The conundrum of antithrombotic therapy in atrial fibrillation patients undergoing TAVI

19 May 2022 – From EuroPCR 2022

Consult this session to learn more about the characteristics of atrial fibrillation patients undergoing TAVI, the priority of stroke prevention in atrial fibrillation patients post-TAVI, as well as the current understanding in Japanese and Asian patients.

Patient risk factors and outcome in contemporary TAVI

17 May 2022 – From EuroPCR 2022

Watch these videos to learn more about the patient's risk factors and outcome after TAVI in various situations: with atrial fibrillation and history of PCI, with Diabetes Mellitus, with aortic stenosis based on cardiac damage, and more!

Patient risk factors and outcome in contemporary TAVI

The uncompromised hemodynamics of the ALLEGRA transfemoral TAVI system in clinical practice

21 Nov 2021 – From PCR London Valves 2021

Join Raúl Moreno, Julian Widder and Mathias Wolfrum  if you want to learn about a single-centre experience of their first 100 patients treated with the ALLEGRA, and to see clinical outcome data on over 250 cases treated with ALLEGRA from a European multicentre registry.

How to manage uncrossable lesions in ACS

15 Nov 2021

Find out more about how the authors managed a 79-year-old male presenting with ACS and lateral ischemia with a calcified and tortuous left circumflex that could not be crossed with balloons... and a 61-year-old male with inferior STEMI presenting with an “undilatable” lesion of the right coronary artery...

Reviewers:

Michele Pighi, Pierre Deharo and Flavio Luciano Ribichini

Challenges and opportunities in high-risk patients undergoing TAVI

19 May 2021 – From EuroPCR 2021

Watch this session presented by Marco Valgimigli, Raul Moreno and Peter Nordbeck in order to discuss the designing TAVI trial for high-risk patients, the timing of TAVI and PCI, as well as the balance between thrombosis prevention and bleeding mitigation

Challenges and opportunities in high-risk patients undergoing TAVI

The uncompromised hemodynamics of the ALLEGRA transfemoral TAVI system in native and small annuli

18 May 2021 – From EuroPCR 2021

Watch this session presented by Raul Moreno and Dave Smith in order to learn about the hemodynamic performance of the ALLEGRA TAVI system, to share the experience of European centres through challenging ALLEGRA cases, and to focus on the outcome of the ALLEGRA TAVI system in small annuli...

The uncompromised hemodynamics of the ALLEGRA transfemoral TAVI system in native and small annuli

Intercostal embolization of a stuck rotational atherectomy burr

02 Mar 2021

An elective right coronary artery PCI was scheduled in an 83-year-old gentleman. Due to the presence of severely diffuse and calcified disease, rotational atherectomy was decided, but the burr got entrapped in the severely calcified and tortuous proximal segment of the artery...

A percutaneous solution to transcatheter aortic valve thrombosis refractory to anticoagulation: valve-in-valve implantation of a supra-annular self-expanding transcatheter aortic valve

03 Aug 2020

A 56-year-old man with severe aortic stenosis underwent transapical TAVR in 2012. In 2017, the patient was referred for exertion dyspnea and transesophageal echocardiogram showed severe stenosis of the bioprosthesis...

Controversies and future perspectives of antithrombotic therapy in atrial fibrillation patients undergoing coronary and valvular transcatheter interventions

23 May 2019 – From EuroPCR 2019

Consult this session to learn about the updated perspective on the bleeding definition in interventional cardiology, and antithrombotic treatment regimens in atrial fibrillation patients undergoing PCI or TAVI.

Controversies and future perspectives of antithrombotic therapy in atrial fibrillation patients undergoing coronary and valvular transcatheter interventions